FDA approves new antibiotics for gonorrhea treatment

The FDA has approved two new oral antibiotics, zoliflodacin (Nuzolvence) and gepotidacin (Blujepa), to treat gonorrhea. These are the first new antibiotics for the infection in decades. The approvals come as gonorrhea is becoming increasingly resistant to existing treatments. Both medications are single-dose or short-course oral treatments, offering alternatives to the current standard injection. Gonorrhea cases have been rising, and untreated infections can lead to serious health problems. The development of these new drugs is seen as a critical step in combating drug-resistant strains of the bacteria.